Cancer researchers at Fox Chase Cancer Center in Philadelphia see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.
Dec 11, 2024
0
0
Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) periodically publishes statistics. Although it is not the most frequent type of cancer, its high lethality ...
Dec 6, 2024
0
0
When it comes to early detection of silent but deadly diseases like pancreatic cancer, finding it early and predicting disease aggressiveness are critical for increasing long-term survival.
Nov 20, 2024
0
2
Experts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in deaths from the disease.
Nov 19, 2024
0
1
November is National Pancreatic Cancer Awareness Month. Approximately 66,000 people in the U.S. will be diagnosed with pancreatic cancer this year, according to the National Cancer Institute.
Nov 13, 2024
0
0
In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A University of California, Riverside team of scientists has used a novel approach to identify protein degraders ...
Nov 11, 2024
0
45
In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of diagnostic methods for pancreatic incidentaloma—incidental findings often detected during imaging scans ...
Nov 8, 2024
0
0
Researchers at the University of Virginia have discovered a new mechanism driving drug resistance in pancreatic ductal adenocarcinoma, one of the deadliest cancers. Their findings could lead to more effective treatments, ...
Nov 7, 2024
0
0
An international research effort led by Charles Sturt University, Australia, is projecting a significant rise in global cancer cases and deaths by 2050. They identify widening disparities between low Human Development Index ...
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic ...
Nov 6, 2024
0
18
